Neuroticism and Mental Health: Why the Trait Is a Transdiagnostic Risk Factor
Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy
Neuroticism is a broad personality trait, not a psychiatric diagnosis. In modern personality science, it describes relatively stable individual differences in the tendency to experience negative emotions and psychological distress across situations and over time. People higher on neuroticism are, on average, more prone to worry, sadness, irritability, self-consciousness, frustration, and feeling overwhelmed; people lower on the dimension are often described as higher in emotional stability. For the Big Five construct itself, see Neuroticism: What It Is in the Big Five Personality Model.
Neuroticism matters to mental health because it is associated with many forms of psychopathology rather than only one disorder. That is what makes it a transdiagnostic risk factor: higher neuroticism can mark elevated statistical vulnerability across diagnostic boundaries, especially for anxiety, depression, and other internalizing problems. A major prospective meta-analysis of 59 studies and 443,313 participants found sizeable unadjusted associations with later anxiety, depression, and nonspecific distress; those associations became smaller after researchers adjusted for baseline symptoms and psychiatric history, but they did not disappear (Jeronimus et al., 2016).
The practical meaning is precise. Neuroticism can help explain why some people are more vulnerable to recurring distress, why anxiety and depressive conditions often share psychological liabilities, and why personality can matter in prevention, assessment, and treatment research. It cannot tell whether a particular person has a disorder, cannot replace a clinical assessment, and cannot be converted into a diagnosis from a raw score, percentile, or online personality test.
What “transdiagnostic risk factor” means
A transdiagnostic factor is a characteristic, process, or liability associated with more than one diagnostic category. The idea is useful because mental disorders do not occur as perfectly isolated boxes. Anxiety and depressive disorders commonly co-occur, symptoms often cross diagnostic boundaries, and broad dimensions such as internalizing distress can capture shared variance among multiple conditions.
Neuroticism fits this framework because its association is broad rather than disorder-specific. Benjamin Lahey’s review described neuroticism as a relatively stable tendency to respond with negative emotion to threat, frustration, or loss and summarized evidence linking it to multiple mental and physical health outcomes (Lahey, 2009). Later work has strengthened the case that neuroticism is especially relevant to the internalizing spectrum, while also showing that the magnitude and meaning of the association differ across conditions.
Calling neuroticism transdiagnostic does not mean that it is a universal cause of mental illness. It means that the trait is associated with risk across several forms of psychopathology, with the strongest and most consistent evidence concentrated in some domains. In the Jeronimus meta-analysis, prospective associations were much larger for anxiety, depression, and nonspecific mental distress than for substance-related or thought-disorder outcomes (Jeronimus et al., 2016). “Transdiagnostic” therefore describes breadth of relevance, not equal predictive power for every diagnosis.
It also does not mean that neuroticism is itself a hidden disorder. Personality traits and psychiatric disorders answer different questions. A trait describes a relatively enduring pattern of individual differences. A disorder is a clinical construct defined by a particular constellation of symptoms, duration, severity, context, distress, impairment, exclusions, and other diagnostic requirements. One person can score high on neuroticism without meeting criteria for any disorder, while another person can meet criteria for a disorder without having an exceptionally high score on every neuroticism measure.
Neuroticism, negative emotionality, and emotional stability
The vocabulary changes across personality models, and careless synonym use can create false precision. In much of the Big Five literature, neuroticism is the conventional label for one broad domain. Emotional stability usually refers to the lower pole of the same broad dimension. In the BFI-2, the domain is labeled Negative Emotionality rather than Neuroticism. These labels overlap strongly in meaning, but a score belongs to the instrument and model that generated it.
The BFI-2, for example, was designed as a hierarchical Big Five measure with broad domains and narrower facets; its Negative Emotionality domain includes Anxiety, Depression, and Emotional Volatility facets (Soto & John, 2017). The NEO tradition operationalizes Neuroticism differently and includes a different facet structure. Eysenck measures place Neuroticism inside the PEN model rather than the Big Five. IPIP instruments can reproduce Big Five- or NEO-like constructs using different item pools and scoring conventions.
This matters clinically because two people labeled “high in neuroticism” may have taken different instruments, used different norms, or reached similar domain scores through different facet profiles. A raw score from one questionnaire cannot be treated as numerically equivalent to a raw score from another. For a detailed measurement guide, see Neuroticism Test: What It Measures and How to Interpret Results, and for the major facet structure used in the NEO tradition, see Neuroticism Facets: Anxiety, Anger, Depression, Self-Consciousness, Impulsiveness, and Vulnerability.
Neuroticism is not the same as negative affect
Negative affect is usually a state-like or shorter-term description of unpleasant emotional experience: feeling anxious, sad, angry, guilty, irritable, or distressed at a particular time or across a relatively limited interval. Neuroticism is a trait-level construct describing a broader tendency to experience such states more readily or intensely across time and situations.
The distinction is statistical rather than absolute. Trait questionnaires are completed in a current psychological state, so current depression, anxiety, stress, sleep disruption, or a recent crisis can influence self-report. Conversely, people with higher neuroticism tend to experience more frequent negative affect. Trait and state therefore correlate, but they are not interchangeable.
This is one reason researchers adjust prospective analyses for baseline symptoms and psychiatric history. If a person is already depressed when neuroticism is measured, part of the elevated score may reflect current distress rather than only a stable vulnerability. The fact that prospective associations shrink after such adjustment is evidence that state and history matter (Jeronimus et al., 2016).
Neuroticism is not the same as anxiety or trait anxiety
Anxiety is an emotion and, in clinical contexts, a symptom domain. An anxiety disorder is a diagnosis. Trait anxiety is a relatively stable tendency to experience anxiety. Neuroticism is broader than all three.
A person high in neuroticism may be especially prone to anxiety, but the trait also includes tendencies toward sadness, anger, self-consciousness, emotional volatility, and vulnerability to stress, depending on the measurement model. Research on depression and anxiety has long found that neuroticism helps account for what the two domains share. In a national sample, Weinstock and Whisman found that high neuroticism was common across depressive and anxiety disorders and especially elevated when the two co-occurred (Weinstock & Whisman, 2006).
The overlap still does not make the constructs identical. Trait anxiety is narrower and anxiety-focused. Neuroticism is a broad personality dimension. Anxiety symptoms can rise sharply during a stressful period even in someone whose long-term personality score is not unusually high. A diagnosed anxiety disorder requires condition-specific assessment rather than inference from a personality score.
Why neuroticism is strongly linked to internalizing psychopathology
The clearest transdiagnostic relationship is with internalizing problems: forms of distress characterized broadly by fear, anxiety, sadness, worry, shame, and related negative emotional states. Anxiety and depressive disorders are central examples, but contemporary dimensional psychopathology models organize internalizing more broadly than a simple two-disorder comparison.
A classic meta-analysis of 175 studies found that anxiety and depressive disorders showed pronounced elevations in neuroticism, while substance use disorders showed a different and generally less neuroticism-dominant profile (Kotov et al., 2010). The same review also found that effect sizes differed by sampling and measurement choices, including weaker neuroticism associations for Eysenck measures than for NEO measures in the included literature. That measurement result is important: “neuroticism” is not a perfectly instrument-free variable.
Research on dimensional psychopathology reaches a compatible conclusion. Neuroticism is strongly related to internalizing dimensions, but internalizing psychopathology and neuroticism are not automatically the same thing. A study of adolescents found a very strong correlation between neuroticism and a latent internalizing factor, illustrating how close the constructs can become in some models and samples (Griffith et al., 2010). That result should not be generalized as a universal correlation for every population or instrument; it is evidence that the shared variance can be substantial.
More recent dimensional work continues to place negative affectivity and neuroticism close to internalizing spectra. A 2024 meta-analytic review of temperament, Five-Factor Model traits, and Hierarchical Taxonomy of Psychopathology domains found a pattern in which temperamental correlates clustered most strongly around neuroticism/internalizing, among other trait-spectrum relationships (Hemmati et al., 2024).
What the prospective evidence actually shows
Cross-sectional association is the easiest evidence to obtain and the easiest to overinterpret. If people with current depression report higher neuroticism than people without depression, several explanations remain possible: neuroticism may increase vulnerability to depression; depression may elevate measured neuroticism; both may reflect shared causes; questionnaire content may overlap; or several processes may operate at once.
Prospective studies improve the temporal question by measuring personality before later outcomes. They still do not automatically establish causality, but they can test whether neuroticism predicts subsequent symptoms or diagnoses.
The strongest broad synthesis here is the 2016 meta-analysis by Jeronimus and colleagues. Across 59 longitudinal or prospective studies involving 443,313 participants, unadjusted prospective associations between neuroticism and later anxiety, depression, and nonspecific mental distress were in the d = 0.50–0.70 range. After adjustment for baseline symptoms and psychiatric history, associations were roughly halved, to d = 0.10–0.40. The adjusted effects remained detectable over longer follow-up intervals (Jeronimus et al., 2016).
That pattern supports two conclusions at the same time. First, neuroticism contains prospective information about later mental-health problems. Second, a substantial part of the raw association reflects pre-existing symptoms, prior disorder, or related factors. A responsible interpretation therefore avoids both extremes: neuroticism is more than a contemporaneous mood score, and it is less than a stand-alone causal explanation of future mental illness.
Depression research illustrates the same complexity. An individual-participant meta-analysis of 10 cohorts, totaling 117,899 participants, found that higher neuroticism was associated with depressive symptoms cross-sectionally and predicted depressive symptoms at follow-up even after baseline depressive symptoms were included in the model. The study also found evidence in the reverse direction: depressive symptoms were associated with later personality change, including higher measured neuroticism (Hakulinen et al., 2015).
Five models for the neuroticism–psychopathology relationship
A useful way to understand the evidence is to separate several models that can operate together. Ormel and colleagues reviewed the relationship between neuroticism and common mental disorders and emphasized that no single model explains all findings (Ormel et al., 2013).
Vulnerability
The vulnerability model proposes that higher neuroticism increases the probability of developing later psychopathology. Mechanisms may include stronger stress appraisal, more frequent negative affect, greater sensitivity to uncertainty or threat, prolonged recovery after stress, worry, rumination, avoidance, interpersonal conflict, or other processes. Longitudinal prediction after adjustment for baseline symptoms is consistent with some vulnerability effect, but it does not prove that the broad trait itself is the direct causal agent.
Common cause
The common-cause model proposes that neuroticism and mental disorders partly arise from shared underlying influences. Those influences can include genetic liabilities, developmental experiences, chronic stress exposure, environmental conditions, and other biological or psychological factors. In this model, neuroticism functions partly as an observable marker of a broader liability.
Genetic evidence supports overlap at the population level. A large 2024 genome-wide investigation found shared genetic architecture between Big Five traits and multiple psychiatric phenotypes, with particularly substantial overlap involving neuroticism and anxiety/depression-related traits (Gupta et al., 2024). Genetic correlation and Mendelian-randomization results are population-level statistical evidence. They do not make neuroticism a genetic diagnosis, identify a deterministic “neuroticism gene,” or allow a personality score to predict an individual person’s psychiatric future with clinical certainty.
Spectrum or content overlap
The spectrum model emphasizes that neuroticism and some forms of psychopathology occupy overlapping psychological territory. A personality item about frequent worry or sadness may resemble symptom content in anxiety or depression scales. This can inflate cross-sectional correlations and complicate claims that one construct independently predicts another.
Content overlap is not a reason to discard neuroticism. It is a reason to interpret it carefully. Broad negative emotionality may genuinely be part of the liability architecture of internalizing psychopathology, while some questionnaires also share wording or emotional content.
State effect
The state model proposes that an active episode of psychopathology temporarily elevates measured neuroticism. Someone answering a personality questionnaire during a severe depressive or anxious episode may endorse more negative-emotionality items than the same person would during sustained remission.
State effects help explain why neuroticism–disorder associations are especially strong in cross-sectional clinical samples and why adjustment for baseline symptoms reduces prospective estimates. They also explain why a change in questionnaire score during treatment cannot automatically be labeled stable personality change.
Scar or lasting change
The scar model proposes that episodes of psychopathology can produce persistent personality change. Evidence is more difficult to establish because researchers must distinguish enduring change from temporary state effects, regression to the mean, measurement error, and developmental trends. The reciprocal associations observed in large longitudinal datasets make lasting change plausible in at least some circumstances, while the size and persistence of such effects vary (Hakulinen et al., 2015).
These models are compatible. The relationship can be partly vulnerability, partly shared liability, partly measurement/content overlap, and partly reciprocal change. Treating one mechanism as the single answer oversimplifies the evidence.
How neuroticism can contribute to risk without being a diagnosis
A broad personality trait can affect mental health through many small pathways rather than one disease-specific mechanism.
People higher in neuroticism tend, on average, to perceive more situations as threatening, stressful, uncertain, frustrating, or personally consequential. They may experience stronger negative emotional responses, recover more slowly from some stressors, and engage more often in worry or rumination. These tendencies can increase cumulative emotional burden.
Behavior can amplify or reduce that burden. Avoidance can provide short-term relief while preserving fear. Reassurance seeking can temporarily reduce uncertainty while maintaining dependence on external certainty. Rumination can extend negative mood. Interpersonal sensitivity can increase conflict or perceived rejection. Sleep disruption, reduced activity, or inconsistent coping can then interact with the original emotional vulnerability. None of these pathways is inevitable, and not every person high in neuroticism shows each one.
Context is equally important. A trait is expressed inside an environment. Chronic adversity, discrimination, unsafe relationships, financial strain, illness, caregiving burden, trauma exposure, occupational demands, and social support can all change the meaning of a person’s emotional sensitivity. The same level of neuroticism may carry different consequences in a stable environment than in a persistently threatening one.
This is why risk-factor language should remain probabilistic. Neuroticism changes average odds and expected levels of distress; it does not dictate an individual trajectory.
Neuroticism and stress are closely connected, but still distinct
Stress provides one plausible bridge between personality and psychopathology. Higher neuroticism is associated with greater perceived stress and, in many studies, stronger negative emotional responses to daily hassles or adversity. Yet neuroticism is not the stressor itself, and perceived stress is not identical to objective exposure.
Three processes can be separated conceptually. Exposure concerns what happens to a person. Appraisal concerns how demanding, threatening, or uncontrollable an event is experienced to be. Reactivity concerns the emotional or physiological response once an event occurs. Neuroticism can relate to appraisal and reactivity, while life circumstances influence exposure.
That separation protects against a common mistake: interpreting higher reported stress as evidence that a person is merely “overreacting.” Reports of stress can reflect genuine differences in exposure, differences in appraisal, differences in emotional reactivity, or combinations of all three. The dedicated Neuroticism and Stress article is a reserved graph target for this cluster and should carry the full stress-specific intent when it is live.
Which mental-health outcomes are most strongly associated?
The broad pattern is not “neuroticism predicts everything equally.” The strongest and most replicated associations concern anxiety, depression, and internalizing or nonspecific psychological distress.
Kotov and colleagues’ meta-analysis found very large elevations in neuroticism across depressive and anxiety disorders, alongside other personality-trait differences (Kotov et al., 2010). Jeronimus and colleagues found the strongest prospective associations for anxiety, depression, and nonspecific distress; prospective associations with substance-related and thought-disorder outcomes were much smaller before adjustment (Jeronimus et al., 2016).
This matters for language. It is reasonable to describe neuroticism as a broad transdiagnostic vulnerability, but the evidence is most coherent when “transdiagnostic” is not mistaken for “equally predictive across all psychiatric diagnoses.”
Associations with obsessive-compulsive symptoms, trauma-related outcomes, eating pathology, somatic distress, personality pathology, psychosis-spectrum phenomena, substance use, ADHD, autism-related measures, and other conditions require condition-specific interpretation. Some relationships may reflect shared distress, comorbidity, symptom overlap, developmental pathways, reporting tendencies, or common genetic/environmental liability. The existence of an association does not mean neuroticism is a symptom criterion for the condition.
For example, obsessive-compulsive disorder is a distinct clinical condition with its own diagnostic and treatment literature. Readers looking for that clinical intent should use the dedicated OCD guide rather than infer OCD from a neuroticism score. Likewise, trauma exposure and post-trauma outcomes have their own causal and clinical questions; the personality-science relationship is discussed separately in Neuroticism and Trauma: Trait Vulnerability, Exposure, and Post-Trauma Outcomes.
Risk factor, correlate, vulnerability, comorbidity, and symptom severity are not synonyms
Mental-health writing often compresses several different statistical ideas into the word “risk.” They should be separated.
A correlate is associated with an outcome at the same or an unspecified time point. It may provide no information about temporal order.
A prospective risk factor is measured before a later outcome and predicts that outcome statistically. This is stronger temporal evidence, but still not automatic proof of causation.
A vulnerability is a broader theoretical idea: a characteristic that may increase susceptibility under some conditions. The term can refer to causal or partially causal processes, but the mechanism must be demonstrated rather than assumed.
Comorbidity means that two or more clinical conditions occur in the same person. Neuroticism is not a comorbid disorder because it is a trait.
Symptom severity describes how intense or extensive symptoms are. A person can have high symptom severity during an episode and later improve substantially while remaining relatively high on a personality trait.
Diagnosis is a clinical classification based on defined criteria and assessment. Neither a personality-risk score nor a statistical association is a diagnosis.
These distinctions are not semantic housekeeping. They determine what conclusions the evidence can support.
Why a high neuroticism score cannot diagnose a disorder
Personality instruments are designed to measure personality dimensions, not to reproduce all diagnostic criteria for anxiety disorders, depressive disorders, OCD, PTSD, ADHD, autism, bipolar disorders, psychotic disorders, eating disorders, substance use disorders, or personality disorders.
A high score may be clinically relevant because it can indicate a broad tendency toward distress. It cannot establish the presence, duration, severity, functional impact, exclusion criteria, differential diagnosis, medical contributors, developmental history, or contextual pattern required for clinical diagnosis.
The meaning of “high” also depends on the measurement system. The NEO PI-R, NEO-FFI, BFI-2 Negative Emotionality scale, IPIP-based measures, Eysenck inventories, and other instruments differ in item content, scale length, facets, scoring, norms, and intended use. A percentile is meaningful only relative to a defined reference sample. A raw score is meaningful only within its scoring system. A T-score or standardized score depends on the normative transformation that produced it.
For this reason, “my neuroticism score is 80” has no universal interpretation without naming the instrument, possible score range, scoring direction, normative group, and population. The Hub’s Neuroticism Score guide explains this issue in detail.
Does high neuroticism mean someone is mentally unhealthy?
No. High neuroticism is neither necessary nor sufficient for poor mental health.
A person can score relatively high on neuroticism and function well, maintain satisfying relationships, work effectively, and have no diagnosable disorder. Emotional sensitivity can coexist with insight, conscientious behavior, social support, effective coping, good sleep, safe circumstances, and access to care. Personality traits describe tendencies, not destinies.
Conversely, a person lower on neuroticism can still develop a mental disorder. Psychiatric outcomes emerge from many interacting influences, including genetics, development, trauma and stress exposure, physical health, substance use, social conditions, cognitive and behavioral processes, and chance. No single Big Five dimension is a universal protective shield.
The most accurate interpretation is comparative and probabilistic: higher neuroticism is associated with greater average vulnerability to distress and several forms of psychopathology, especially internalizing problems. Individual outcome depends on far more than the trait.
Does neuroticism cause depression and anxiety?
The evidence supports prospective prediction and shared liability more confidently than a simple one-way causal story.
Longitudinal meta-analysis shows that neuroticism measured earlier predicts later anxiety and depression even after adjustment for baseline symptoms and psychiatric history, although the effect becomes substantially smaller after those adjustments (Jeronimus et al., 2016). That pattern is compatible with vulnerability.
At the same time, depressive symptoms can predict later changes in measured neuroticism (Hakulinen et al., 2015). Genetic studies identify overlap between neuroticism and psychiatric traits, pointing to shared liability rather than complete independence (Gupta et al., 2024). Content overlap between personality and symptom measures can further increase associations.
Causal language therefore needs levels. “Associated with” is well established. “Prospectively predicts” is supported for important outcomes. “Contributes to vulnerability” is plausible and supported by multiple designs. “Causes a disorder in a particular individual” is far stronger than current trait evidence can establish.
The genetics of neuroticism do not make it a biological diagnosis
Neuroticism is partly heritable at the population level, and modern genome-wide studies identify many genetic variants that contribute tiny effects to personality differences. The architecture is polygenic: there is no single neuroticism gene, and genetic contribution does not imply immutability.
Shared genetic correlations between neuroticism and depression, anxiety, and other psychiatric phenotypes help explain why personality and psychopathology can cluster. They do not tell whether one person with a particular neuroticism score will develop a disorder. Genetic correlation is a property of variation in populations, not a diagnostic label attached to an individual.
Likewise, brain, endocrine, or cortisol correlates should be interpreted at the group level unless a validated individual clinical application exists. Neuroticism is not diagnosed by an MRI, stress-hormone test, genotype, or polygenic score. The cluster reserves those biological questions for dedicated pages so that association, heritability, mechanism, and causality are not collapsed into one claim.
Can mental illness temporarily increase measured neuroticism?
Yes. Current mental state can influence self-reported personality, which is one reason state effects are a central part of the literature.
During an episode of major depression, severe anxiety, trauma-related distress, insomnia, or another period of sustained psychological strain, a person may endorse more items about worry, sadness, irritability, vulnerability, or emotional volatility. When symptoms improve, some of those endorsements may decline.
This does not mean personality scores are meaningless. It means trait measurement is never performed outside time. Researchers distinguish stable between-person differences from within-person fluctuation by using repeated measurement, long follow-up, informant reports, latent-state/trait models, and adjustment for symptoms or psychiatric history.
The issue is especially important when interpreting change during treatment. If both depression symptoms and a neuroticism score fall over 12 weeks, the personality result may reflect genuine trait change, symptom-driven state change, measurement overlap, or a mixture. Study design determines how confidently those possibilities can be separated.
Can treatment reduce neuroticism?
Psychotherapy is used to treat mental-health problems, not because neuroticism is a disease that must be “cured.” Still, researchers have asked whether interventions can change measured neuroticism.
A randomized trial of the Unified Protocol for emotional disorders found larger reductions in measured neuroticism for the transdiagnostic Unified Protocol than for diagnosis-specific CBT protocols or a waitlist at the primary comparison point, with differences remaining after simultaneous changes in anxiety and depression were modeled (Sauer-Zavala et al., 2021). This is evidence that personality-related measures can shift under intervention. It does not establish that every person should seek therapy to lower a personality trait or that all symptom improvement represents enduring trait change.
Longer-term personality research also shows that adult traits are relatively stable but not fixed. The key conceptual distinctions are mean-level change in a population, individual change, state fluctuation, and durable trait change. The dedicated change/intervention pillar is reserved for the full question of whether and how neuroticism changes; this page keeps the focus on mental-health risk.
Medication raises the same boundary issue. Psychiatric medication may reduce symptoms of a diagnosed condition and can sometimes coincide with changes in self-reported personality. That does not make neuroticism an illness with a standard medication treatment. Decisions about medication belong to the diagnosed condition, clinical indication, evidence base, risks, and individual medical context.
Why the association can look stronger in clinical samples
Effect sizes depend on who is studied and how constructs are measured.
Clinical samples contain more people with current or severe symptoms than general-population samples. Current distress can elevate neuroticism scores, and restricted comparison groups can magnify contrasts. Case-control designs can therefore produce very large differences without answering how much neuroticism predicts first onset in the population.
Kotov and colleagues reported that personality–psychopathology effects varied by sampling approach and measurement instrument (Kotov et al., 2010). Jeronimus and colleagues showed how baseline symptoms and psychiatric history substantially reduced prospective effect sizes (Jeronimus et al., 2016).
This is why a single dramatic effect size should not be treated as the universal “impact of neuroticism.” The estimate belongs to a study design, population, measure, outcome, and follow-up interval.
Neuroticism can help explain comorbidity
Comorbidity is one of the strongest reasons transdiagnostic constructs matter. If anxiety and depression share a broad liability toward negative emotionality, the same person may be vulnerable to multiple symptom patterns over time rather than one perfectly isolated disorder.
Neuroticism can therefore function as part of an explanation for why internalizing disorders cluster. Weinstock and Whisman found elevated neuroticism across depressive and anxiety disorders and especially high levels among people with comorbid depression and anxiety (Weinstock & Whisman, 2006). Dimensional taxonomies similarly organize multiple diagnoses under broader spectra partly because observed psychopathology has hierarchical structure rather than strict independence.
This does not mean neuroticism fully explains comorbidity. Shared genetics, stress exposure, learning processes, cognitive mechanisms, social context, developmental timing, and direct causal relations among symptoms can all contribute. Neuroticism is one broad layer in a multi-level system.
Neuroticism and the general psychopathology “p factor”
Another transdiagnostic idea is the general psychopathology factor, often called the p factor. Statistical models sometimes identify a broad dimension that captures what diverse forms of psychopathology share, with narrower internalizing, externalizing, and thought-disorder dimensions beneath or alongside it.
Neuroticism is often associated with broad psychopathology, but the two concepts should not be collapsed. Neuroticism is a normal-range personality trait measured across the population. A p factor is a latent statistical dimension derived from patterns of psychopathology indicators. The constructs can correlate strongly because both capture broad liability toward distress or dysfunction, while still differing in item content, modeling assumptions, and interpretation.
Systematic work on transdiagnostic psychopathology supports the existence of broad dimensions and highlights shared genetic and neurobiological correlates, but these models are research frameworks rather than individual diagnostic tests (Hoy et al., 2023). A person does not receive a clinical diagnosis of “high p factor” from having a high neuroticism score.
What neuroticism can and cannot add to clinical assessment
In clinical research and some assessment contexts, personality information can add useful context. It can help characterize chronic emotional style, identify broad vulnerability, explain why symptoms recur across diagnostic categories, or inform case formulation.
Its value is greatest when it is integrated with condition-specific information. A clinician assessing panic, depression, OCD, trauma-related symptoms, substance use, or another problem needs the person’s symptom pattern, duration, impairment, medical and developmental context, risk factors, history, and differential diagnosis. Neuroticism can be part of that picture without replacing it.
A personality score also should not be used as an automatic screening result for a disorder. Screening tools answer narrower questions about the probability of clinically relevant symptoms and still require follow-up assessment. Neuroticism instruments measure a personality dimension.
For self-understanding, a high score can be framed as a prompt for questions rather than a verdict: Which emotions are most frequent? What situations trigger them? How long does recovery take? Is worry useful problem-solving or repetitive rumination? Does distress impair sleep, work, relationships, or daily functioning? Are symptoms episodic or longstanding? Those questions move from a broad trait toward the actual clinical or practical issue.
When higher neuroticism becomes clinically relevant
There is no personality cutoff at which neuroticism “becomes a disorder.” Clinical relevance comes from what is happening in the person’s life and mental health.
Professional evaluation becomes more relevant when negative emotional states are persistent, severe, escalating, difficult to regulate, or associated with substantial distress or impairment; when panic, compulsions, trauma symptoms, depressive episodes, disordered eating, substance-related problems, psychotic symptoms, mania, or other condition-specific concerns appear; or when the person is unsure whether a longstanding personality style has shifted into a new clinical problem.
The purpose of assessment is not to decide whether someone is “too neurotic.” It is to identify the actual symptoms, context, risks, functional effects, and possible diagnoses that need attention.
Practical implications of knowing your neuroticism level
A neuroticism result is most useful when it improves understanding rather than identity labeling.
Someone higher on the trait may benefit from recognizing recurring patterns of threat appraisal, worry, rumination, emotional escalation, avoidance, reassurance seeking, or slow recovery from stress. That recognition can support more deliberate coping, earlier response to emerging symptoms, better sleep and stress management, and clearer communication about emotional needs. The relevant intervention depends on the actual problem; there is no universal “neuroticism treatment.”
Someone lower on the trait can still miss or minimize distress, delay help-seeking, or experience disorders whose symptoms are not captured well by broad negative emotionality. Lower neuroticism is not proof of psychological health.
For researchers and clinicians, the trait can serve as a broad risk marker, covariate, moderator, or treatment-related outcome when measured with a specified instrument. For individuals, it is better understood as one dimension of personality among many rather than a psychiatric label.
Frequently asked questions
Is neuroticism a mental illness?
No. Neuroticism is a dimensional personality trait. Higher neuroticism is associated with greater average risk for several mental-health problems, but the trait itself is not a psychiatric diagnosis.
Why is neuroticism called a transdiagnostic risk factor?
Because higher neuroticism is associated with multiple forms of psychopathology across diagnostic boundaries, especially anxiety, depression, and broader internalizing distress. The strength of association varies across conditions, and transdiagnostic does not mean equally predictive of every disorder.
Does high neuroticism mean I have anxiety or depression?
No. A high personality score cannot diagnose anxiety or depression. It may indicate greater general vulnerability to negative emotional states, but diagnosis requires condition-specific symptoms, duration, severity, impairment, and clinical context.
Is neuroticism the same as emotional instability?
They overlap, but terminology depends on the model. Emotional stability is commonly treated as the opposite pole of neuroticism. The BFI-2 uses Negative Emotionality as its domain label and includes Emotional Volatility as one narrower facet.
Is neuroticism the same as negative affect?
No. Negative affect usually refers to unpleasant emotional experience over a shorter time frame or as a state. Neuroticism is a broader trait-level tendency to experience negative affect more frequently or intensely across time and situations.
Is neuroticism the same as trait anxiety?
No. Trait anxiety specifically concerns a relatively stable proneness to anxiety. Neuroticism is broader and includes several kinds of negative emotionality beyond anxiety.
Which disorders are most strongly related to neuroticism?
The strongest broad evidence concerns anxiety disorders, depressive disorders, and nonspecific/internalizing distress. Associations exist with other forms of psychopathology, but effect sizes and mechanisms differ, so condition-specific conclusions require condition-specific evidence.
Does neuroticism cause mental disorders?
Neuroticism prospectively predicts several mental-health outcomes and likely contributes to vulnerability, but the relationship is not a simple one-way causal pathway. Shared genetic and environmental factors, current symptoms, measurement overlap, reciprocal effects, and other mechanisms also contribute.
Can depression or anxiety make a neuroticism score higher?
Yes. Current symptoms can elevate self-reported neuroticism, which is called a state effect. This is one reason longitudinal studies adjust for baseline symptoms and psychiatric history and why score changes during treatment must be interpreted carefully.
Can neuroticism change with therapy?
Measured neuroticism can change, and randomized intervention research has reported reductions in some treatment contexts. A lower score can reflect enduring trait change, symptom-related state change, or both. Neuroticism itself is not a disease that requires treatment.
Is there a cutoff for “clinically high” neuroticism?
There is no universal clinical cutoff across neuroticism measures. Interpretation depends on the specific instrument, score metric, normative sample, population, and purpose. A high percentile on a personality test is not a psychiatric diagnosis.
Can a neuroticism test predict whether I will develop a disorder?
It can contribute statistical information about group-level risk, especially for internalizing problems, but it cannot predict an individual’s future with certainty. Mental-health outcomes depend on many interacting factors, and neuroticism is only one of them.
Conclusion
Neuroticism is one of the most important personality dimensions for understanding mental-health vulnerability because it captures a broad, relatively stable tendency toward negative emotionality and distress. Across decades of research, higher neuroticism has been associated with multiple forms of psychopathology and prospectively predicts later problems, most consistently anxiety, depression, and internalizing distress.
Its transdiagnostic importance comes from breadth, not diagnostic equivalence. Neuroticism is a personality trait; anxiety, depression, OCD, PTSD, ADHD, autism, bipolar disorder, psychotic disorders, eating disorders, substance use disorders, and personality disorders are distinct clinical or neurodevelopmental constructs with their own assessment frameworks. A high neuroticism score can mark vulnerability without establishing any of them.
The strongest interpretation is therefore layered. Neuroticism may contribute to vulnerability; current symptoms can influence measured personality; personality and psychopathology share genetic and environmental liabilities; some questionnaire content overlaps; and episodes of disorder may sometimes alter later personality. The relationship is reciprocal and multi-causal rather than a single pathway.
For readers, the useful question is not “Does high neuroticism mean I am mentally ill?” It is “What does this personality tendency tell me about how I experience and respond to stress, and are there actual symptoms or impairments that deserve condition-specific attention?” That distinction preserves the value of personality science without turning a trait into a diagnosis.
Related Articles
Neuroticism Facets: Anxiety, Anger, Depression, Self-Consciousness, Impulsiveness, and Vulnerability
References
Griffith, J. W., Zinbarg, R. E., Craske, M. G., Mineka, S., Rose, R. D., Waters, A. M., & Sutton, J. M. (2010). Neuroticism as a common dimension in the internalizing disorders. Psychological Medicine, 40(7), 1125–1136. https://doi.org/10.1017/S0033291709991449
Gupta, P., Galimberti, M., Liu, Y., et al. (2024). A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology. Nature Human Behaviour, 8, 2235–2249. https://doi.org/10.1038/s41562-024-01951-3
Hakulinen, C., Elovainio, M., Pulkki-Råback, L., Virtanen, M., Kivimäki, M., & Jokela, M. (2015). Personality and depressive symptoms: Individual-participant meta-analysis of 10 cohort studies. Depression and Anxiety, 32(7), 461–470. https://doi.org/10.1002/da.22376
Hemmati, A., Rezaei, F., Rahmani, K., Komasi, S., Miettunen, J., Amianto, F., & Clark, L. A. (2024). Meta-analytic review of temperamental correlates of the Five-Factor Model and Hierarchical Taxonomy of Psychopathology domains. Indian Journal of Psychological Medicine, 46(3), 208–220. https://doi.org/10.1177/02537176231210396
Hoy, N., Lynch, S. J., Waszczuk, M. A., Reppermund, S., & Mewton, L. (2023). Transdiagnostic biomarkers of mental illness across the lifespan: A systematic review examining the genetic and neural correlates of latent transdiagnostic dimensions of psychopathology in the general population. Neuroscience & Biobehavioral Reviews, 155, 105431. https://doi.org/10.1016/j.neubiorev.2023.105431
Jeronimus, B. F., Kotov, R., Riese, H., & Ormel, J. (2016). Neuroticism’s prospective association with mental disorders halves after adjustment for baseline symptoms and psychiatric history, but the adjusted association hardly decays with time: A meta-analysis on 59 longitudinal/prospective studies with 443,313 participants. Psychological Medicine, 46(14), 2883–2906. https://doi.org/10.1017/S0033291716001653
Kotov, R., Gamez, W., Schmidt, F., & Watson, D. (2010). Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis. Psychological Bulletin, 136(5), 768–821. https://doi.org/10.1037/a0020327
Lahey, B. B. (2009). Public health significance of neuroticism. American Psychologist, 64(4), 241–256. https://doi.org/10.1037/a0015309
Ormel, J., Jeronimus, B. F., Kotov, R., Riese, H., Bos, E. H., Hankin, B., Rosmalen, J. G. M., & Oldehinkel, A. J. (2013). Neuroticism and common mental disorders: Meaning and utility of a complex relationship. Clinical Psychology Review, 33(5), 686–697. https://doi.org/10.1016/j.cpr.2013.04.003
Sauer-Zavala, S., Fournier, J. C., Steele, S. J., Woods, B. K., Wang, M., Farchione, T. J., & Barlow, D. H. (2021). Does the Unified Protocol really change neuroticism? Results from a randomized trial. Psychological Medicine, 51(14), 2378–2387. https://doi.org/10.1017/S0033291720000975
Soto, C. J., & John, O. P. (2017). The next Big Five Inventory (BFI-2): Developing and assessing a hierarchical model with 15 facets to enhance bandwidth, fidelity, and predictive power. Journal of Personality and Social Psychology, 113(1), 117–143. https://doi.org/10.1037/pspp0000096
Weinstock, L. M., & Whisman, M. A. (2006). Neuroticism as a common feature of the depressive and anxiety disorders: A test of the revised integrative hierarchical model in a national sample. Journal of Abnormal Psychology, 115(1), 68–74. https://doi.org/10.1037/0021-843X.115.1.68